F.D.A. Rejects Closely Watched Lung Cancer Drug From China
16 Nov 2026, 02:45 AM

F.D.A. Rejects Closely Watched Lung Cancer Drug From China

T
TNY Times
@tnytimes
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Source Credit: nytimes.com
Read Full Story
6

Comments (0)

Login to join the conversation